PCR Analysis: Number of Patients and Normal Controls PCR Positive for VEGF, KDR, or FLT-1 Per Number of Studied Subjects According to FAB Type
| . | VEGF . | KDR . | FLT-1 . |
|---|---|---|---|
| M0 | 1/1 (100) | 0/1 (0) | 0/1 (0) |
| M1 | 4/5 (80) | 0/2 (0) | 3/3 (100) |
| M2 | 2/3 (67) | 2/2 (100) | 1/2 (50) |
| M3 | 5/6 (83) | 0/4 (0) | 0/2 (0) |
| M4 | 6/11 (54) | 2/11 (18) | 5/9 (55) |
| M5 | 2/2 (100) | 0/2 (0) | 1/2 (50) |
| M6 | ND | ND | 0/1 (0) |
| Total | 20/28 (71) | 4/22 (18) | 10/20 (50) |
| Sek. AML | 3/5 (60) | 1/4 (25) | 3/5 (60) |
| Total | 23/32 (72) | 5/26 (19) | 13/25 (52) |
| Normal | 2/7 (28) | 0/8 (0) | 2/6 (33) |
| CD34+ | 1/3 (33) | 0/3 (0) | 1/3 (33) |
| . | VEGF . | KDR . | FLT-1 . |
|---|---|---|---|
| M0 | 1/1 (100) | 0/1 (0) | 0/1 (0) |
| M1 | 4/5 (80) | 0/2 (0) | 3/3 (100) |
| M2 | 2/3 (67) | 2/2 (100) | 1/2 (50) |
| M3 | 5/6 (83) | 0/4 (0) | 0/2 (0) |
| M4 | 6/11 (54) | 2/11 (18) | 5/9 (55) |
| M5 | 2/2 (100) | 0/2 (0) | 1/2 (50) |
| M6 | ND | ND | 0/1 (0) |
| Total | 20/28 (71) | 4/22 (18) | 10/20 (50) |
| Sek. AML | 3/5 (60) | 1/4 (25) | 3/5 (60) |
| Total | 23/32 (72) | 5/26 (19) | 13/25 (52) |
| Normal | 2/7 (28) | 0/8 (0) | 2/6 (33) |
| CD34+ | 1/3 (33) | 0/3 (0) | 1/3 (33) |
Values are the number positive/total number, with percentages in parentheses.
Abbreviation: ND, not done.